Abstract
At the onset and progression of neurodegenerative diseases, enhanced reactive oxygen species (ROS) and an overall uncompensated oxidative stress environment evolve. Oxidized phospholipids (OxPLs) cause detrimental perturbations to synaptic membranes and other parts of the nervous system. We tested if the lipid mediators Elovanoids (ELVs) that exert neuroprotective signaling also counteract lipid peroxidation using an experimental ischemic stroke model. Male Sprague-Dawley rats after 2 hours of middle cerebral artery occlusion (MCAo) were used. ELV-N34 was administered intranasally at 1 hour, 24 hours and 48 hours after, and rats were sacrificed on day 3; the brains were removed and sampled into the right and left hemispheres and the cortex, subcortex. Untargeted lipidomics were performed using a Waters Xevo G2-XS QTof system under MSE mode, and collected MS/MS spectra for the OxPLs was processed and searched against a reference spectral library by MS-DIAL software. ELV-N34 reduced oxidized phosphatidylcholine (OxPC) and phosphatidylethanolamine (OxPE) molecular species. We suggest that ELVs target lipid peroxidation as part of their neuroprotective bioactivity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
